9265 YAMASHITA HEALTH CARE HOLDINGS,INC. - Financial Results

About Information Provided on This Site

The information provided on our website 'Kabutan.com' is not intended to constitute investment solicitation or investment advisory services.
All investment decisions should be made at your own discretion and judgment.
The data on our website is provided by Tokyo Stock Exchange, Osaka Exchange, Nagoya Securities Exchange, JPX Market Innovation & Research, Japannext, and other sources.
Copyright of the Nikkei Stock Average belongs to Nikkei Inc. Stock price charts displayed on Kabutan.com are provided solely for the purpose of reviewing historical price movements of the securities.
These charts neither suggest nor guarantee future price movements of the securities and do not constitute recommendations to buy or sell.
In our financial results coverage, the term 'Surprise Results' identifies securities that demonstrate a significant degree of surprise in their earnings announcements.
This significance is quantitatively assessed based on multiple factors, including: the nature of the announcement (full-year or quarterly results); types of revisions (earnings or dividend forecasts); and numerical analysis comparing the announced results with both the company's previous forecasts and historical performance.
The 'Surprise Ranking' presents these results in order of their calculated surprise factor. Please note that neither these results nor rankings are intended to suggest or guarantee future performance of the listed securities, nor should they be construed as recommendations to buy or sell.

9265

TSE Standard

YAMASHITA HEALTH CARE HOLDINGS,INC.

2,770

JPY

+150

(+5.73%)

Apr 10, 9:07 am JST

18.79

USD

Apr 9, 8:07 pm EDT

Result

PTS

outside of trading hours

ー

Summary Chart Historical News Financial Result

Current Period Guidance

Annual

Result

Guidance History

Growth Rate

Profitability

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Adj. Dividend	Announce	Accounting Standards
May, 2021	70,131	968	1,026	678	265.8	90	Jul 14, 2021	J-GAAP
May, 2022	55,145	930	1,003	696	272.7	82	Jul 14, 2022	J-GAAP
May, 2023	58,195	1,156	1,206	219	85.8	48	Jul 14, 2023	J-GAAP
May, 2024	61,555	967	1,020	580	228.0	70	Jul 12, 2024	J-GAAP
May, 2025 Guidance	67,319	771	821	509	206.4	61	Jul 12, 2024	J-GAAP
YoY	+9.4%	-20.3%	-19.5%	-12.2%	-9.5%

Revision Direction	Revision Date	Revenue	Operating Profit	Ordinary Profit	Net Profit	Revised Dividend	Accounting Standards
May, 2020	Jul 12, 2019	62,581	397	453	267	32	J-GAAP
	Jan 8, 2020	63,780	561	639	423	45	J-GAAP
Results	Jul 13, 2020	64,658	560	642	459	54	J-GAAP
May, 2021	Jul 13, 2020	Available in future release
	Mar 30, 2021
	Jul 6, 2021
Results	Jul 14, 2021
May, 2022	Jul 14, 2021
	Mar 31, 2022
Results	Jul 14, 2022
May, 2023	Jul 14, 2022
	Mar 31, 2023
Results	Jul 14, 2023
May, 2024	Jul 14, 2023
	Mar 29, 2024
Results	Jul 12, 2024
May, 2025	Jul 12, 2024	67,319	771	821	509	61	J-GAAP

Fiscal Year	Revenue	YoY	Operating Profit	YoY	Ordinary Profit	YoY	Adj. EPS	YoY
Apr, 2001	23,666	－	Available in future release
May, 2001 Changed	1,560	－
May, 2002	28,229	+1,709.6
May, 2003	28,277	+0.2
May, 2004	28,731	+1.6
May, 2005	30,793	+7.2
May, 2006	32,464	+5.4
May, 2007	33,221	+2.3
May, 2008	35,718	+7.5
May, 2009	36,399	+1.9
May, 2010	39,385	+8.2
May, 2011	40,059	+1.7
May, 2012	44,325	+10.6
May, 2013	47,132	+6.3
May, 2014	51,049	+8.3
May, 2015	50,310	-1.4
May, 2016	51,615	+2.6
May, 2017	52,517	+1.7
May, 2018	58,692	+11.8
May, 2019	61,533	+4.8
May, 2020	64,658	+5.1
May, 2021	70,131	+8.5
May, 2022	55,145	-21.4
May, 2023	58,195	+5.5
May, 2024	61,555	+5.8
May, 2025 Guidance	67,319	+9.4	771	-20.3	821	-19.5	206.4	-9.5

Fiscal Year	Revenue	Operating Profit	Operating Profit Margin	ROE	ROA	Total Asset Turnover Ratio	Adj. EPS
May, 2023	58,195	1,156	1.99	2.76	0.90	2.39	85.8
May, 2024	61,555	967	1.57	7.05	2.27	2.41	228.0
May, 2025 Guidance	67,319	771	1.15	5.85	1.99	2.63	206.4

All-Time High

	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS
Record	70,131	1,156	1,206	696	652.0
Fiscal Year	May, 2021	May, 2023	May, 2023	May, 2022	May, 2005

Second Half

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Adj. Dividend	Announce	Accounting Standards
Dec - May, 2021	27,810	267	302	225	88.2	82	Jul 14, 2022	J-GAAP
Dec - May, 2022	30,534	558	582	420	164.6	48	Jul 14, 2023	J-GAAP
Dec - May, 2023	32,656	349	375	100	39.3	70	Jul 12, 2024	J-GAAP
Dec - May, 2024 Guidance	35,957	249	269	171	69.3	61	Jan 14, 2025	J-GAAP
YoY	+10.1%	-28.7%	-28.3%	+71.0%	+76.4%

Cash Flow

Annual

Fiscal Year	Operating Profit	Fee Cash Flow	Operating Cash Flow	Investing Cash Flow	Financial Cash Flow	Cash & Equivalents	Cash Ratio	Accounting Standards
May, 2022	930	554	581	-27	-229	3,975	16.50	J-GAAP
May, 2023	1,156	2,059	2,166	-107	-209	5,825	23.71	J-GAAP
May, 2024	967	-189	878	-1,067	-335	5,300	19.96	J-GAAP

Actual Performance and Financial Trends

Accumulated Results 3rd Quarter

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Progress Rate vs. First Half	Announce	Accounting Standards
Jun - Feb, 2022	41,725	895	936	1	0.5	77.6	Mar 31, 2023	J-GAAP
Jun - Feb, 2023	45,373	830	871	442	173.2	85.4	Mar 29, 2024	J-GAAP
Jun - Feb, 2024	47,552	714	759	461	186.7	92.4	Mar 31, 2025	J-GAAP
YoY	+4.8%	-14.0%	-12.9%	+4.3%	+7.8%

Quarterly Results

Result

Growth Rate

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Operating Profit Margin	Announce	Accounting Standards
Mar - May, 2023	16,470	261	270	218	85.4	1.6	Jul 14, 2023	J-GAAP
Jun - Aug, 2023	14,021	196	213	162	63.5	1.4	Sep 29, 2023	J-GAAP
Sep - Nov, 2023	14,878	422	432	318	124.6	2.8	Jan 12, 2024	J-GAAP
Dec - Feb, 2023	16,474	212	226	-38	-14.9	1.3	Mar 29, 2024	J-GAAP
Mar - May, 2024	16,182	137	149	138	54.2	0.8	Jul 12, 2024	J-GAAP
Jun - Aug, 2024	15,183	178	193	83	33.7	1.2	Sep 30, 2024	J-GAAP
Sep - Nov, 2024	16,179	344	359	255	103.2	2.1	Jan 14, 2025	J-GAAP
Dec - Feb, 2024	16,190	192	207	123	49.8	1.2	Mar 31, 2025	J-GAAP
YoY	-1.7%	-9.4%	-8.4%	－	－

Fiscal Year	Revenue	YoY	Operating Profit	YoY	Ordinary Profit	YoY	Adj. EPS	YoY
Mar - May, 2020	16,712	-2.6	Available in future release
Jun - Aug, 2020	15,528	-2.8
Sep - Nov, 2020	16,974	-0.8
Dec - Feb, 2020	17,281	+16.3
Mar - May, 2021	20,348	+21.8
Jun - Aug, 2021	12,885	-17.0
Sep - Nov, 2021	14,450	-14.9
Dec - Feb, 2021	13,301	-23.0
Mar - May, 2022	14,509	-28.7
Jun - Aug, 2022	13,471	+4.5
Sep - Nov, 2022	14,190	-1.8
Dec - Feb, 2022	14,064	+5.7
Mar - May, 2023	16,470	+13.5
Jun - Aug, 2023	14,021	+4.1
Sep - Nov, 2023	14,878	+4.8
Dec - Feb, 2023	16,474	+17.1
Mar - May, 2024	16,182	-1.7
Jun - Aug, 2024	15,183	+8.3
Sep - Nov, 2024	16,179	+8.7
Dec - Feb, 2024	16,190	-1.7	192	-9.4	207	-8.4	49.8	－

All-Time High Quarterly Results

	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS
Record	20,348	461	480	327	128.3
Fiscal Year	May, 2021	Nov, 2021	Nov, 2021	Nov, 2019	Nov, 2019

Key Balance Sheet Figures

Fiscal Year	BPS	Equity Ratio	Total Asset	Equity	Retained Earnings	Interest-Bearing Debt Ratio	Announce	Accounting Standards
May, 2022	3,126.18	33.1	24,086	7,980	6,296	ー	Jul 14, 2022	J-GAAP
May, 2023	3,097.34	32.2	24,568	7,907	6,306	ー	Jul 14, 2023	J-GAAP
May, 2024	3,429.08	32.2	26,557	8,542	6,763	ー	Jul 12, 2024	J-GAAP
Jun - Feb, 2024	ー	34.0	25,622	8,707	7,050	ー	Mar 31, 2025	J-GAAP

YAMASHITA HEALTH CARE HOLDINGS,INC.(9265) Financial Results